These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 11063821)
1. Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis. Tuohy VK; Yu M; Yin L; Mathisen PM; Johnson JM; Kawczak JA J Neuroimmunol; 2000 Nov; 111(1-2):55-63. PubMed ID: 11063821 [TBL] [Abstract][Full Text] [Related]
2. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis. Tuohy VK; Yu M; Yin L; Kawczak JA; Kinkel RP J Exp Med; 1999 Apr; 189(7):1033-42. PubMed ID: 10190894 [TBL] [Abstract][Full Text] [Related]
3. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis. Yu M; Johnson JM; Tuohy VK J Neurosci Res; 1996 Aug; 45(4):463-70. PubMed ID: 8872907 [TBL] [Abstract][Full Text] [Related]
4. Pre-emptive targeting of the epitope spreading cascade with genetically modified regulatory T cells during autoimmune demyelinating disease. Yin L; Yu M; Edling AE; Kawczak JA; Mathisen PM; Nanavati T; Johnson JM; Tuohy VK J Immunol; 2001 Dec; 167(11):6105-12. PubMed ID: 11714769 [TBL] [Abstract][Full Text] [Related]
5. 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis. Nath N; Giri S; Prasad R; Salem ML; Singh AK; Singh I J Immunol; 2005 Jul; 175(1):566-74. PubMed ID: 15972693 [TBL] [Abstract][Full Text] [Related]
6. Determinant-regulated onset of experimental autoimmune encephalomyelitis: distinct epitopes of myelin proteolipid protein mediate either acute or delayed disease in SJL/J mice. Tuohy VK; Thomas DM; Haqqi T; Yu M; Johnson JM Autoimmunity; 1995; 21(3):203-14. PubMed ID: 8822278 [TBL] [Abstract][Full Text] [Related]
7. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. Yu M; Johnson JM; Tuohy VK J Exp Med; 1996 Apr; 183(4):1777-88. PubMed ID: 8666934 [TBL] [Abstract][Full Text] [Related]
8. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Zhang X; Koldzic DN; Izikson L; Reddy J; Nazareno RF; Sakaguchi S; Kuchroo VK; Weiner HL Int Immunol; 2004 Feb; 16(2):249-56. PubMed ID: 14734610 [TBL] [Abstract][Full Text] [Related]
9. IFN-β regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis. Zhao Q; Cheng W; Xi Y; Cao Z; Xu Y; Wu T; Li C; Niu X; Chen G Mol Immunol; 2018 Jan; 93():20-30. PubMed ID: 29127843 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide. Karpus WJ; Kennedy KJ; Smith WS; Miller SD J Neurosci Res; 1996 Aug; 45(4):410-23. PubMed ID: 8872901 [TBL] [Abstract][Full Text] [Related]
12. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. McRae BL; Vanderlugt CL; Dal Canto MC; Miller SD J Exp Med; 1995 Jul; 182(1):75-85. PubMed ID: 7540658 [TBL] [Abstract][Full Text] [Related]
13. Suppression of ongoing experimental allergic encephalomyelitis (EAE) in Lewis rats: synergistic effects of myelin basic protein (MBP) peptide 68-86 and IL-4. Xu LY; Huang YM; Yang JS; Van Der Meide PH; Link H; Xiao BG Clin Exp Immunol; 2000 Jun; 120(3):526-31. PubMed ID: 10844533 [TBL] [Abstract][Full Text] [Related]
14. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809 [TBL] [Abstract][Full Text] [Related]
15. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread. Takács K; Chandler P; Altmann DM Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820 [TBL] [Abstract][Full Text] [Related]
16. IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice. Nagelkerken L; Blauw B; Tielemans M Int Immunol; 1997 Sep; 9(9):1243-51. PubMed ID: 9310827 [TBL] [Abstract][Full Text] [Related]
17. IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis. Young DA; Lowe LD; Booth SS; Whitters MJ; Nicholson L; Kuchroo VK; Collins M J Immunol; 2000 Apr; 164(7):3563-72. PubMed ID: 10725711 [TBL] [Abstract][Full Text] [Related]
18. Regression and spreading of self-recognition during the development of autoimmune demyelinating disease. Tuohy VK; Yu M; Yin L; Kawczak JA; Kinkel PR J Autoimmun; 1999 Aug; 13(1):11-20. PubMed ID: 10441163 [TBL] [Abstract][Full Text] [Related]
19. Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis. Zhang GX; Yu S; Gran B; Li J; Siglienti I; Chen X; Calida D; Ventura E; Kamoun M; Rostami A J Immunol; 2003 Nov; 171(9):4485-92. PubMed ID: 14568921 [TBL] [Abstract][Full Text] [Related]
20. Ethanol extract of Glycyrrhizae Radix modulates the responses of antigen-specific splenocytes in experimental autoimmune encephalomyelitis. Yang EJ; Song IS; Song KS Phytomedicine; 2019 Feb; 54():56-65. PubMed ID: 30668383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]